Sarepta Therapeutics financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$0.43M $4.78M $0.12M $10.99M $21.26M $17.59M $29.42M $46.99M $37.33M $14.22M $9.76M $1.25M $5.42M $154.58M $301.03M $380.83M $540.10M $701.89M $933.01M $1.24B $0.00M
GM % Gross Margin %
0.00% -233.58% 0.00% -182.73% -28.57% -38.73% 100.00% -41.23% -39.12% 0.00% 0.00% 0.00% 0.00% 95.24% -43.55% -62.09% -45.46% -23.63% -8.37% 17.34% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% -286.65% -82.52% -88.18% -71.16% -74.12% -78.00% 0.00% 0.00% 0.00% 0.00% -92.25% -113.59% -137.10% -104.44% -64.00% -56.83% -21.54% 0.00%
EPS Earnings Per Share
$-2.22 $-3.54 $-3.00 $-2.04 $-1.62 $-1.74 $-0.12 $-5.14 $-2.63 $-3.32 $-4.44 $-3.94 $-1.51 $-2.14 $-4.30 $-5.83 $-3.80 $-3.06 $-0.64 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 -0.00% 0 0 0 0 0 0 0 -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% 0
Sha. Shares
6.02m 8.53m 8.86m 10.74m 11.86m 18.41m 18.72m 22.62m 29.25m 37.58m 41.31m 45.27m 54.59m 64.63m 70.51m 74.54m 78.51m 78.91m 87.08m 93.55m 93.55m
OCF Operating Cash Flow
$-23.78M $-14.67M $-20.61M $-24.68M $-12.34M $-8.80M $-15.21M $-23.68M $-29.69M $-64.70M $-128.54M $-149.47M $-245.82M $-232.00M $-388.66M $-456.46M $107.47M $-443.17M $-325.35M $-500.99M $0.00M
FCF Free Cash Flow
$-24.85M $-15.74M $-21.38M $-25.95M $-12.71M $-9.73M $-16.04M $-24.86M $-29.80M $-67.07M $-153.98M $-152.87M $-251.16M $-244.00M $-449.82M $-516.09M $25.26M $-481.66M $-356.17M $-503.00M $0.00M
FCFS Free Cash Flow Per Share
$-4.22 $-2.17 $-2.51 $-2.98 $-1.17 $-0.70 $-0.93 $-1.20 $-1.31 $-2.02 $-3.88 $-3.65 $-5.19 $-2.18 $-6.84 $-7.05 $1.71 $-4.67 $-4.07 $-5.26 $0.00